RT @TerezaKasaeva
On the occasion of #WorldTBDay please see our @TheLancet Comment: Fast-tracking progress to #EndTB: high-level opportunities for investment and action - with @paimadhu & @HMonica_Dias #YesWeCanEndTB https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2823%2900460-9/fulltext

Heute ist #WeltTuberkuloseTag! Die Forschenden am @ForschungszentrumBorstel
sind stolz darauf seit 75 Jahren zur Erforschung der #Tuberkulose beizutragen und immer wieder neue Impulse zur Verbesserung der Überwachung, Diagnose und Behandlung der TB setzen zu können. #EndTB #YesWeCanEndTB

Want some #WeekendReading? Our @UNITE4TB@twitter.com project has been looking at #TB diagnostics...
➡️Read our news story: http://bit.ly/3JJs2LV
➡️Read the paper in @ERSpublications@twitter.com Breathe: http://bit.ly/3lEzobK
#WorldTBDay #YesWeCanEndTB

Predict-TB was IMI's first #TB project – it developed tools which drug developers can use to increase the probability of them choosing the right drug-like compounds and getting them through clinical trials successfully.
➡️http://bit.ly/3qyXfZD
#YesWeCanEndTB #WorldTBDay

#Tuberculosis is one of the focus areas of @imi_eupearl@twitter.com, which is setting up adaptive clinical trial platforms to make trials more efficient and patient-friendly.
➡️http://bit.ly/3JEoQjw
#YesWeCanEndTB #WorldTBDay

RESPIRI-TB aims to advance the development of new drug candidates that could be part of a new, more effective, shorter regimen to treat multi-drug resistant #TB.
➡️http://bit.ly/3tCYV6u
#YesWeCanEndTB #WorldTBDay

Our @TRIC_TB@twitter.com project is advancing the development of compounds that boost the infection-fighting ability of existing TB drugs. After successful trials under TRIC-TB, one compound is now being developed further through @EDCTP@twitter.com
https://bit.ly/3A3zE7d
#YesWeCanEndTB #WorldTBDay

Our @UNITE4TB@twitter.com project is pioneering a new approach to #ClinicalTrials of #tuberculosis drug regimens that will test different regiments in parallel, dramatically speeding up the trial process.
➡️http://bit.ly/3qtGWx1
#YesWeCanEndTB #WorldTBDay

Our @IMI_ERA4TB@twitter.com project is developing a #TB drug development platform to allow scientists to study the safety & efficacy of multiple drug combinations in parallel. This should speed up the development of new treatment regimens.
➡️http://bit.ly/35arXAU
#YesWeCanEndTB #WorldTBDay

On #WorldTBDay2023, meet the IMI projects working to #EndTB... starting with our @AMRAccelerator@twitter.com which has projects dedicated to #tuberculosis #TB - @IMI_ERA4TB@twitter.com @UNITE4TB@twitter.com @TRIC_TB@twitter.com & RESPIRI-TB
#YesWeCanEndTB

On #WorldTBDay, read how our @UNITE4TB@twitter.com project is exploring how low- & middle-income countries could roll out the molecular diagnostic tests needed to determine the best treatment for people diagnosed with #tuberculosis #TB
➡️http://bit.ly/3JJs2LV
#YesWeCanEndTB

Heute ist #Welttuberkulosetag.

Jährlich wird am 24.3. für die gesundheitlichen, sozialen und wirtschaftlichen Folgen der Tuberkulose sensibilisiert und dafür geworben die Anstrengungen zur Beendigung der weltweiten Tuberkuloseepidemie zu verstärken.

#YesWeCanEndTB #WorldTBDay

Fast 1.000 Teilnehmende (online), abwechslungsreiche Referent:innen & Grußworte von Gesundheitsminister @Karl_Lauterbach
Auf unserer jährlichen Tagung im Vorfeld des #Welttuberkulosetags gab es heute Vorträge zu #Tuberkulosekontrolle & -versorgung sowie zu #PublicHealth-Aspekten. #YesWeCanEndTB

2/
Das #EpidBull steht ganz im Zeichen der #Tuberkulose
🔵#Welttuberkulosetag 2023: #YesWeCanEndTB
🔵Tuberkulose bei Patienten/-innen mit Geburtsland Ukraine in Deutschland im Jahr 2022
🔵Aktualisierung der DZK-Empfehlungen zur Infektionsprävention

➡️https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/11_23.html